CTS Spotlight at 2018 AABB Annual Meeting
Sunday, October 14, 2018 at 1:30 PM: Scientific Oral Abstract Plenary Session (BBC57) Multicenter Clinical Evaluation of a Babesia Transcription-Mediated Amplification Assay on a Fully Automated System Phillip C. Williamson, Ph.D.
Monday, October 15, 2018 at 2:30PM: (BBC2-MN3-24) Recently Acquired Hepatitis C Infections in US Blood Donors: Genotype and Geographic Distribution of NAT Yield Blood Donations across the Continental US Valerie Winkelman and Phillip C. Williamson, Ph.D.
Tuesday, October 16, 2018 at 11:45AM a: (PHP2 - TU3-23) Characteristics of HIV Infections, Including Genotypes and Drug Resistance Mutations, in Blood Donors in the US Phillip C. Williamson, Ph.D.
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
The new online Learning Center with new content can still be found under the “Training” folder on ...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...